Bartoloni et al., "Engineering Bacterial Toxin for the Development of New Vaccine against Pertussis," Tokai J. Exp. Clin. Med., 13(Suppl):217-22 (1988). |
Beattie et al., "Evidence that Modulation Requires Sequences Downstream of the Promoters of Two vir-Repressed Genes of Bordetella pertussis," J. Bacteriol., 172/12:6997-7004 (1990). |
Beattie et al., "Repressor Binding to a Regulatory Site in the DNA Coding Sequence Is Sufficient To Confer Transcriptional Regulation of the vir-Repressed Genes (vrg Genes) in Bordetella pertussis," J. Bacteriol., 175/2:519-27 (1993)). |
Beattie et al., "A vir-Repressed Gene of Bordetella pertussis is Required for Virulence," Infection and Immunity, 60/2:571-577 (1992). |
Betsou et al., "CyaC-Mediated Activation is Important Not Only for Toxic but Also for Protective Activities of Bordetella pertussis Adenylate Cyclase-Hemolysin," Infection and Immunity, 61/9:3583-3589 (1993). |
Brennan et al., "Identification of a 69-Kilodalton Nonfimbrial Protein as an Agglutinogen of Bordetella pertussis," Infection and Immunity, 56/12:3189-3195 (1988). |
Charles et al., "Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis", Proc. Natl. Acad. Sci. USA, 86:3554-3558 (1989). |
Friedman, "Bordetella pertussis Adenylate Cyclase: Isolation and Purification by Calmodulin-Sepharose 4B Chromatography", Infection and Immunity, 55/1:129-134 (1987). |
Goldman et al., "Spontaneous phase variation in Bordetella pertussis is a multistep non-random process," EMBO Journal, 3/6:1353-1356 (1984). |
Grimprel et al., "Long-Term Human Serum Antibody Responses after Immunization with Whole-Cell Pertussis Vaccine in France," Clinical & Diagostic Laboratory Immunology, 3/1:93-97 (1996). |
Gross et al., "Targeted mutations that ablate either the adenylate cylase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence," Proc. Natl. Acad. Sci. USA, 89:4898-4902 (1992). |
Gueirard et al., Human Bordetella bronchiseptica Infection Related to Contact with Infected Animals: Persistence of Bacteria in Host, J. Clin. Microbiol., 33/8:2002-2006 (1995). |
Gueirard et al., Human Bordetella bronchiseptica Infection Related to Contact with Infected Animals: Persistence of Bacteria in Host, J. Clin. Microbiol., 33/8:2002-2006 (1995). |
Gueirard et al., "Virulence of Bordetella bronchiseptica: Role of Adenylate Cyclase-Hemolysin," Infection & Immunity, 61/10:4072-4078 (1993). |
Gueirard et al., "Virulence of Bordetella bronchiseptica," Bacterial Protein Toxins, ed. Freer et al., Suppl. 24:152-153 (1994). |
Glaser et al., "The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli", Molecular Microbiology 2/1:19-30 (1988). |
Guiso et al., Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization, Microbial Pathogenesis, 11:423-431 (1991). |
Hackett et al., "Hemolytic, but Not Cell-invasive Activity, of Adenylate Cyclase Toxin is Selectively Affected by Differential Fatty-acylation in Escherichia coli", The Journal of Biological Chemistry, 270/35:20250-20253 (1995). |
Hackett et al., Internal Lysine Palmitoylation in Adenylate Cyclase Toxin from Bordetella pertussis, Science, 226:433-435 (1994). |
Hausman et al., Analysis of Proteins Encoded by the ptx and ptl Genes of Bordetella bronchiseptica and Bordetella parapertussis, Infection and Immunity, 64/10:4020-4026 (1996). |
Hewlett et al., "Adenylate Cyclase Toxin from Bordetella pertussis: Identification and Purification of the Holotoxin Molecule", The Journal of Biological Chemistry, 264/32: 19379-19384 (1989). |
Horiguchi et al., Effects of Bordetella bronchiseptica Dermonecrotic Toxin on the Structure and Function of Osteoblastic Clone MC3T3-E1 Cells, Infection and Immunity 59/3:1112-1116 (1991). |
Iwaki et al., "Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin", Molecular Microbiology, 17/6:1015-1024 (1995). |
Kessin et al., "Secreted Adenylate Cyclase of Bordetella pertussis: Calmodulin Requirements and Partial Purification of Two Forms," Journal of Bacteriology, 166/1:290-296 (1986). |
Khelef et al., "Characterization of Murine Lung Inflammation after Infection with Parental Bordetella pertussis and Mutants Deficient in Adhesions or Toxins," Infectin and Immunity, 62/7:2893-2900 (1994). |
Khelef et al., "Bordetella Species are Immunologically Different," Bacterial Protein Toxins ed. Freer et al., Suppl. 24:514-515 (1994). |
Khelef et al., "Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection," Microbial Pathogenesis, 12:227-235 (1992). |
Knapp et al., "Two trans-Acting Regulatory Genes (vir and mod) Control Antigenic Modulation in Bordetella pertussis," J. Bacteriol. 170/11:5059-5066 (1988). |
Ladant et al., "Bordetella pertussis Adenylate Cyclase: Purification, Characterization and Radioimmunoassay," The Journal of Biological Chemistry, 261/34:16264-162169 (1986). |
Le Blay et al., "Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica," Microbiology, 143:1433-1441 (1997). |
Munoz et al., Mouse-Protecting and Histamine-Sensitizing Activities of Pertussigen and Fimbrial Hemagglutinin from Bordetella pertussis, Infection and Immunity,32/1:243-250 (1981). |
Novotny et al., "Adenylate Cyclase Activity of a 68,000-Molecular-Weight Protein Isolated from the Outer Membrane of Bordetella bronchiseptica," Infection and Immunity, 50/1:199-206 (1985). |
Novotny et al., "Biologic and Protective Properties of the 69-kDa Outer Membrane Protein of Bordetella pertussis: A Novel Formulation for an Acellular Pertussis Vaccine," Journal of Infectious Diseases, 164:114-22 (1991). |
Novotny, "Bordetella Adenylate Cyclase: A Genus Specific Protective Antigen and Virulence Factor," Proceedings of the Fourth International Symposium on Pertussis, Developed Biol. Standard, 61:27-41 (1985). |
Passerini de Rossi et al., "Flagellin, a major protein present in SDS-Page profiles of Sarkosyl-OMP-enriched fractions from Bordetella bronchiseptica Bvg--or modulated Bvg+ strains," Veterinary Microbiology, 56:65-77 (1997). |
Pittman, "Pertussis Toxin: The Cause of the Harmful Effects and Prolonged Immunity of Whooping Cough. A Hypothesis," Reviews of Infectious Diseases, 1/3:401-412 (1979). |
Shattuck et al., "Purification and Characterization of a Calmodulin-Sensitive Adenylate Cyclase from Bordetella pertussis," Biochemistry, 24:6356-6362 (1985). |
Beattie et al. Journal of Bacteriology 172(12):6997-7004, 1990. |
Beattie et al. Infection and Immunity 60(2):571-577, 1992. |
Beattie et al. Journal of Bacteriology 175(2):519-527, 1993. |
Knapp et al. Journal of Bacteriology 170(11):5059-5066, 1988. |